Literature DB >> 15080495

Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.

Sang-Han Lee1, Ho-Young Kim, Tae-Jung Kim, Hyun-Kyoung Park, Woo-Hyoung Kim, Kee-Min Woo, Man-Hee Cho.   

Abstract

Alterations of the FHIT gene occur as frequent events in several human cancers. Replacement of exogenous wild-type FHIT gene has been shown to induce suppression of tumorigenicity of human FHIT-negative cells in nude mice and aberrant FHIT transcripts have been observed in a variety of human solid tumors. In the presence study, we performed a nested reverse transcription-polymerase chain reaction (RT-PCR) analysis to identify aberrant FHIT transcripts in 6 gastric cancer cell lines. In addition to the wild-type FHIT transcript, small-sized transcripts with various number and lengths were observed in all of the cell lines examined. Sequence analysis confirmed that different types of truncated transcripts included exonic deletions, insertions of intron 5 sequences between exons, and combinations of both. Most of these transcripts lacked exon 5 in which translation initiation codon is located. Aberrant transcripts with partial exonic deletions, resulting from activation of cryptic splice sites, were also observed in 5 cell lines. Additionally, multi-step splice patterns, indicative of additional downstream processing, were observed in several cancer lines. Our results suggest that the aberrant FHIT transcripts in gastric cancer cell lines resulted from faulty splicing, including exon skipping, selection of cryptic splice site and additional downstream splice processing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15080495

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  4 in total

1.  Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker.

Authors:  Emma Bragantini; Stefano Barbi; Stefania Beghelli; Patrick S Moore; Giovanni de Manzoni; Franco Roviello; Anna Tomezzoli; Carla Vindigni; Raffaele Baffa; Aldo Scarpa
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-11       Impact factor: 4.553

Review 2.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

3.  Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.

Authors:  Rong-Hua Xu; Liang-Yan Zheng; Dong-Lei He; Jian Tong; Li-Ping Zheng; Wu-Ping Zheng; Jin Meng; Li-Ping Xia; Cong-Jun Wang; Ji-Lin Yi
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

4.  Alternative splicing and tumor progression.

Authors:  Claudia Ghigna; Cristina Valacca; Giuseppe Biamonti
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.